Sensex tanks over 500 points: 3 reasons why the stock market is falling today

The BSE Sensex was trading at 76,866.60, down 603.51 points or 0.78%, while the NSE Nifty50 fell 160.75 points, or 0.66%, to 24,026.95 around 9:35 am.

In Short

• Pharma stocks slide on US tariff concerns, Nifty Pharma falls 1.70%
• Brent crude climbs above $92, raising inflation and cost worries
• Auto sector and Titan show gains amid market weakness

Benchmark stock market indices witnessed sharp selling in early trade on Wednesday, with the Sensex tumbling nearly 600 points and the Nifty slipping below the 24,050 mark, as weakness in pharma and banking stocks, surging crude oil prices and broad-based selling across sectors weighed on investor sentiment.

The BSE Sensex was trading at 76,866.60, down 603.51 points or 0.78%, while the NSE Nifty50 fell 160.75 points, or 0.66%, to 24,026.95 around 9:35 am.

The sell-off was widespread, with almost every major sector trading in the red. The Nifty Smallcap 100 fell 1.10%, while the Nifty Midcap 100 and Nifty Midcap 50 declined 0.70% and 0.74%, respectively. India VIX rose 2.79%, signalling higher market volatility.

Here are the three key reasons behind today's decline.

PHARMA STOCKS SLIDE ON US TARIFF CONCERNS

The biggest drag on the market came from pharmaceutical stocks after US President Donald Trump outlined a phased tariff plan on imported generic medicines, giving drugmakers a two-year window before the duties take effect.

The Nifty Pharma index fell 1.70%, making it the worst-performing sector in early trade.

Selling was visible across the pharma pack. Gland Pharma dropped 3.57%, PPL Pharma declined 3.28%, Alkem Laboratories fell 2.97%, Lupin lost 2.92%, Ajanta Pharma slipped 2.88% and Aurobindo Pharma was down 2.79%.

The weakness extended to the broader healthcare space as well. The Nifty Healthcare index declined 1.50%, while the Nifty MidSmall Healthcare index fell nearly 2%. Stocks such as Glenmark (-2.60%), Biocon (-1.62%) and Laurus Labs (-1.33%) also came under pressure.

The sharp decline in healthcare stocks weighed heavily on the benchmark indices, given the sector's significant representation in the broader market.

BRENT CRUDE CLIMBS ABOVE $92

Another major concern for investors was the continued surge in crude oil prices amid escalating tensions in the Middle East.

Brent crude rose 1.16% to $92.07 per barrel, its highest level since June, while WTI crude climbed 1.03% to $85.21.

Higher crude prices are considered negative for India, the world's third-largest crude importer, as they increase the country's import bill, fuel inflation and raise input costs for businesses.

The rise in oil prices has also heightened concerns about corporate profit margins, particularly for sectors such as aviation, paints, chemicals and FMCG that are sensitive to raw material costs.

Dr. VK Vijayakumar, Chief Investment Strategist at Geojit Investments Limited, said geopolitics and crude oil remain the biggest near-term risks for the market.

"The continuing US-Iran conflict and rising Brent crude price will continue to weigh on markets despite positive news on other fronts. The early automobile Q1 numbers are impressive and management commentary reflects optimism. Exports, too, are doing well," he said.

BROAD-BASED SELLING ACROSS SECTORS

The decline was not limited to one or two sectors, with 10 of the 16 major sectoral indices trading in the red.

Banking stocks remained under pressure. The Nifty PSU Bank index fell 1.38%, while the Nifty Private Bank index declined 1.09%. Nifty Financial Services slipped 0.97%.

Among frontline stocks, SBI dropped 1.46%, Axis Bank declined 1.34%, ICICI Bank fell 1.28%, HDFC Bank lost 0.99% and Kotak Mahindra Bank slipped 0.78%.

Technology stocks also witnessed selling, with the Nifty IT index falling 0.73%. Tech Mahindra declined 1.15%, Infosys fell 0.91% and TCS slipped 0.39%.

Reliance Industries lost 0.71%, while Adani Ports, Cement, Sun Pharma and Trent were among other notable losers.

The only bright spot was the auto sector, where the Nifty Auto index gained 0.37% after encouraging June-quarter updates from automobile companies. Titan was also among the few Sensex gainers, rising 0.64%.

Despite the ongoing weakness, Vijayakumar believes the correction could offer opportunities for long-term investors.

"The price correction in some of the leading banking names appears to be over. There is value in this segment. Dips in the market will provide buying opportunities in fundamentally sound stocks. The outperformance of the broader market may continue in the near term," he said.

He also noted that the rupee is likely to remain supported by strong FCNR deposit inflows, which have crossed $20 billion, while foreign investors have largely stayed away from heavy selling and have turned buyers on some trading sessions.

(Disclaimer: The views, opinions, recommendations, and suggestions expressed by experts/brokerages in this article are their own and do not reflect the views of the India Today Group. It is advisable to consult a qualified broker or financial advisor before making any actual investment or trading choices.)

- Ends